Could extended CPAP save preterm Babies' lungs?

NCT ID NCT07417111

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether keeping very preterm babies on CPAP (a breathing machine) until 34 weeks after conception, instead of switching to a nasal cannula, reduces their risk of bronchopulmonary dysplasia (a chronic lung disease) or death. About 860 infants born before 29 weeks will be enrolled. The goal is to see if longer CPAP support leads to better lung outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CPAP (continuous positive airway pressure) device

What this could lead to

If it works, this could show that keeping very preterm babies on CPAP longer helps prevent a serious lung disease called bronchopulmonary dysplasia.

What could go wrong

This is a large trial but still early in testing. The results may not apply to all preterm infants, and CPAP can cause discomfort or nasal injury.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.